메뉴 건너뛰기




Volumn 94, Issue 6, 2000, Pages 475-481

Use of bone density measurements within therapeutic and preventive strategies of osteoporosis. Example of a systematic evaluation (HTA);Stellenwert der osteodensitometrie im rahmen von prävention und therapie der osteoporose: Beispiel einer systematischen verfahrensbewertung in der medizin (Health Technology Assessment)

Author keywords

Bone Densitometry; Health Technology Assessment; Osteoporosis

Indexed keywords

BONE DENSITY; FRACTURE; HUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; RADIODENSITOMETRY; REVIEW; RISK FACTOR;

EID: 0034243056     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (27)
  • 1
    • 0030911520 scopus 로고    scopus 로고
    • Introduction to the EUR-ASSESS report
    • Banta D (1997) Introduction to the EUR-ASSESS Report. Internat J Techn Assess Health Care 13(2): 133-143
    • (1997) Internat J Techn Assess Health Care , vol.13 , Issue.2 , pp. 133-143
    • Banta, D.1
  • 2
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    • Fracture Intervention Trial Research Group
    • Black DM, Cummings SR, Karpf DB, et al (1996) Randomised Trial of Effect of Alendronate on Risk of Fracture in Women with existing Vertebral Fractures. Fracture Intervention Trial Research Group. Lancet 348(9041): 1535-1541
    • (1996) Lancet , vol.348 , Issue.9041 , pp. 1535-1541
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3
  • 3
    • 0030010992 scopus 로고    scopus 로고
    • Diphosphonates: And alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate
    • Buffo L, Rossini M, Buoncristiano A, et al (1996) [Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] Minerva-Ginecol 48(6): 263-72
    • (1996) Minerva-ginecol , vol.48 , Issue.6 , pp. 263-272
    • Buffo, L.1    Rossini, M.2    Buoncristiano, A.3
  • 4
    • 0029116697 scopus 로고
    • Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
    • Chesnut CH 3rd, McClung MR, Ensrud KE, et al (1995) Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med. 99(2): 144-52
    • (1995) Am J Med. , vol.99 , Issue.2 , pp. 144-152
    • Chesnut C.H. III1    McClung, M.R.2    Ensrud, K.E.3
  • 5
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108 411 women without breast cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast Cancer and Hormone Replacement Therapy: Collaborative Reanalysis of data from 51 epidemiological studies of 52705 Women with breast Cancer and 108 411 women without breast cancer. Lancet 350: 1047-1059
    • (1997) Lancet , vol.350 , pp. 1047-1059
  • 6
    • 0028963682 scopus 로고
    • Risk factors for hip fracture in white women
    • Cummings SR, Nevitt MC, Browner WS, et al (1995) Risk factors for hip fracture in white women. N Engl J Med 332(12): 767-773
    • (1995) N Engl J Med , vol.332 , Issue.12 , pp. 767-773
    • Cummings, S.R.1    Nevitt, M.C.2    Browner, W.S.3
  • 7
    • 0032583492 scopus 로고    scopus 로고
    • Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures
    • Cummings SR, Black DM, Thompson DE, et al (1998) Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures. JAMA 280(24): 2077-2082
    • (1998) JAMA , vol.280 , Issue.24 , pp. 2077-2082
    • Cummings, S.R.1    Black, D.M.2    Thompson, D.E.3
  • 9
    • 0031056019 scopus 로고    scopus 로고
    • Perimenopausal bone density screening: Will it help prevent osteoporosis
    • Garton MJ, Cooper C, Reid C (1997) Perimenopausal bone density screening: will it help prevent osteoporosis. Maturitas 26(1): 35-43
    • (1997) Maturitas , vol.26 , Issue.1 , pp. 35-43
    • Garton, M.J.1    Cooper, C.2    Reid, C.3
  • 12
    • 0030610461 scopus 로고    scopus 로고
    • Postmenopausal hormone therapy and mortality
    • Grodstein F, Stampfer MJ, Colditz GA, et al (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336(25): 1769-1775
    • (1997) N Engl J Med , vol.336 , Issue.25 , pp. 1769-1775
    • Grodstein, F.1    Stampfer, M.J.2    Colditz, G.A.3
  • 13
    • 0031862370 scopus 로고    scopus 로고
    • The effectiveness of bone density measurement and associated treatments for prevention of fractures: An International Collaborative Review
    • Hailey D, Sampietro-Colom L, Marshall D, et al (1998) The Effectiveness of Bone Density Measurement and Associated Treatments for Prevention of Fractures: An International Collaborative Review. Internat J Techn Assess Health Care 14(2): 237-255
    • (1998) Internat J Techn Assess Health Care , vol.14 , Issue.2 , pp. 237-255
    • Hailey, D.1    Sampietro-Colom, L.2    Marshall, D.3
  • 14
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
    • Hulley S, Grady D, Bush T, Furberg C, Herrington D (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group [see comments]. JAMA: 280(7): 605-13
    • (1998) JAMA , vol.280 , Issue.7 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3    Furberg, C.4    Herrington, D.5
  • 15
    • 25044440444 scopus 로고
    • Memorandum zur evaluierung diagnostischer maßnahmen. Im auftrag der arbeitsgruppe "methoden der prognose- und entscheidungsfindung" in der deutschen gesellschaft für medizinische dokumentation, informatik und statistik e.V. (GMDS)
    • Köbberling J, Trampisch HJ, Windeler J (1989) Memorandum zur Evaluierung diagnostischer Maßnahmen. Im Auftrag der Arbeitsgruppe "Methoden der Prognose- und Entscheidungsfindung" in der Deutschen Gesellschaft für Medizinische Dokumentation, Informatik und Statistik e.V. (GMDS). Nucl Med 28: 255-60
    • (1989) Nucl Med , vol.28 , pp. 255-260
    • Köbberling, J.1    Trampisch, H.J.2    Windeler, J.3
  • 16
    • 0028851590 scopus 로고
    • Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
    • Liberman UA, Weiss SR, Bröll J, et al (1995) Effect of oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis. N Engl J Med 333: 1437-43
    • (1995) N Engl J Med , vol.333 , pp. 1437-1443
    • Liberman, U.A.1    Weiss, S.R.2    Bröll, J.3
  • 17
    • 23844454398 scopus 로고    scopus 로고
    • Die rolle der osteodensitometrie im rahmen der primär-, sekundär und tertiärprävention/therapie der osteoporose
    • Baden-Baden: Nomos Verlagsgesellschaft
    • Lühmann D, Kohlmann T, Lange S, Raspe H (2000) Die Rolle der Osteodensitometrie im Rahmen der Primär-, Sekundär und Tertiärprävention/Therapie der Osteoporose. Schriftenreihe des DIMDI im Auftrag des Bundesministeriums für Gesundheit. Band 13. Baden-Baden: Nomos Verlagsgesellschaft
    • (2000) Schriftenreihe des DIMDI Im Auftrag des Bundesministeriums für Gesundheit , vol.13
    • Lühmann, D.1    Kohlmann, T.2    Lange, S.3    Raspe, H.4
  • 18
    • 0029986509 scopus 로고    scopus 로고
    • Meta-analysis of how well measures of bone mineral density predict occurence of osteoporotic fractures
    • Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurence of osteoporotic fractures. BMJ 312: 1254-1259
    • (1996) BMJ , vol.312 , pp. 1254-1259
    • Marshall, D.1    Johnell, O.2    Wedel, H.3
  • 19
    • 0030931725 scopus 로고    scopus 로고
    • Recommendations for the application of bone density measurement. What can you believe?
    • Marshall DA, Sheldon TA, Jonsson E (1997) Recommendations for the application of bone density measurement. What can you believe? Internat J Techn Assess Health Care 13(3): 411-419
    • (1997) Internat J Techn Assess Health Care , vol.13 , Issue.3 , pp. 411-419
    • Marshall, D.A.1    Sheldon, T.A.2    Jonsson, E.3
  • 20
    • 0025765521 scopus 로고
    • Pre-existing fractures and bone mass predict vertebral fracture incidence in women
    • Ross PD, Davis JW, Epstien RS, Wasnich R (1991) Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women. Ann Intern Med 114(11): 919-923
    • (1991) Ann Intern Med , vol.114 , Issue.11 , pp. 919-923
    • Ross, P.D.1    Davis, J.W.2    Epstien, R.S.3    Wasnich, R.4
  • 21
    • 0028119643 scopus 로고
    • Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
    • Rossini M, Gatti D, Zamberlan N, et al (1994) Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Min Res 9(11): 1833-1837
    • (1994) J Bone Min Res , vol.9 , Issue.11 , pp. 1833-1837
    • Rossini, M.1    Gatti, D.2    Zamberlan, N.3
  • 23
    • 0031000660 scopus 로고    scopus 로고
    • Bone density measurement - A systematic review
    • SBU (1997) Bone Density Measurement - A systematic review. J Inter Med 241 (Suppl. 739): 1-60
    • (1997) J Inter Med , vol.241 , Issue.739 SUPPL. , pp. 1-60
  • 24
    • 0025366467 scopus 로고
    • Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate of women with postmenopausal osteoporosis
    • Storm T, Thamsborg G, Steiniche T, Genant HK, Sörensen OH (1990) Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate of Women with Postmenopausal Osteoporosis. N Engl J Med 322: 1265-71
    • (1990) N Engl J Med , vol.322 , pp. 1265-1271
    • Storm, T.1    Thamsborg, G.2    Steiniche, T.3    Genant, H.K.4    Sörensen, O.H.5
  • 26
    • 0025334778 scopus 로고
    • Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
    • Watts NB, Harris ST, Genant HK, et al (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323: 73-9
    • (1990) N Engl J Med , vol.323 , pp. 73-79
    • Watts, N.B.1    Harris, S.T.2    Genant, H.K.3
  • 27
    • 0029960173 scopus 로고    scopus 로고
    • Developing evidence-based clinical practice guidelines: Lessons learnt by the U.S. Preventive Services Task Force
    • Woolfe SH, DiGuiseppi CG, Atkins D, Kamerow DB (1996) Developing Evidence-Based Clinical Practice Guidelines: Lessons learnt by the U.S. Preventive Services Task Force. Ann Rev Publ Health 17:511-38
    • (1996) Ann Rev Publ Health , vol.17 , pp. 511-538
    • Woolfe, S.H.1    DiGuiseppi, C.G.2    Atkins, D.3    Kamerow, D.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.